Literature DB >> 21922599

Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study.

Renata Smieskova1, Paul Allen, Andor Simon, Jacqueline Aston, Kerstin Bendfeldt, Jürgen Drewe, Kerstin Gruber, Ute Gschwandtner, Markus Klarhoefer, Claudia Lenz, Klaus Scheffler, Rolf-Dieter Stieglitz, Ernst-Wilhelm Radue, Philip McGuire, Anita Riecher-Rössler, Stefan J Borgwardt.   

Abstract

OBJECTIVES: Neurofunctional alterations are correlates of vulnerability to psychosis, as well as of the disorder itself. How these abnormalities relate to different probabilities for later transition to psychosis is unclear. We investigated vulnerability- versus disease-related versus resilience biomarkers of psychosis during working memory (WM) processing in individuals with an at-risk mental state (ARMS). EXPERIMENTAL
DESIGN: Patients with "first-episode psychosis" (FEP, n = 21), short-term ARMS (ARMS-ST, n = 17), long-term ARMS (ARMS-LT, n = 16), and healthy controls (HC, n = 20) were investigated with an n-back WM task. We examined functional magnetic resonance imaging (fMRI) and structural magnetic resonance imaging (sMRI) data in conjunction using biological parametric mapping (BPM) toolbox. PRINCIPAL OBSERVATIONS: There were no differences in accuracy, but the FEP and the ARMS-ST group had longer reaction times compared with the HC and the ARMS-LT group. With the 2-back > 0-back contrast, we found reduced functional activation in ARMS-ST and FEP compared with the HC group in parietal and middle frontal regions. Relative to ARMS-LT individuals, FEP patients showed decreased activation in the bilateral inferior frontal gyrus and insula, and in the left prefrontal cortex. Compared with the ARMS-LT, the ARMS-ST subjects showed reduced activation in the right inferior frontal gyrus and insula. Reduced insular and prefrontal activation was associated with gray matter volume reduction in the same area in the ARMS-LT group.
CONCLUSIONS: These findings suggest that vulnerability to psychosis was associated with neurofunctional alterations in fronto-temporo-parietal networks in a WM task. Neurofunctional differences within the ARMS were related to different duration of the prodromal state and resilience factors.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21922599      PMCID: PMC6870404          DOI: 10.1002/hbm.21360

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  88 in total

1.  Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study.

Authors:  P Fusar-Poli; M R Broome; J B Woolley; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  J Psychiatr Res       Date:  2010-06-30       Impact factor: 4.791

Review 2.  Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.

Authors:  P Fusar-Poli; S Borgwardt; A Crescini; G Deste; Matthew J Kempton; S Lawrie; P Mc Guire; E Sacchetti
Journal:  Neurosci Biobehav Rev       Date:  2010-12-17       Impact factor: 8.989

3.  Biological parametric mapping: A statistical toolbox for multimodality brain image analysis.

Authors:  Ramon Casanova; Ryali Srikanth; Aaron Baer; Paul J Laurienti; Jonathan H Burdette; Satoru Hayasaka; Lynn Flowers; Frank Wood; Joseph A Maldjian
Journal:  Neuroimage       Date:  2006-10-27       Impact factor: 6.556

Review 4.  The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Authors:  R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI.

Authors:  D S Manoach; D Z Press; V Thangaraj; M M Searl; D C Goff; E Halpern; C B Saper; S Warach
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

6.  Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia.

Authors:  David C Glahn; J Daniel Ragland; Adir Abramoff; Jennifer Barrett; Angela R Laird; Carrie E Bearden; Dawn I Velligan
Journal:  Hum Brain Mapp       Date:  2005-05       Impact factor: 5.038

7.  Radiological findings in individuals at high risk of psychosis.

Authors:  S J Borgwardt; E-W Radue; K Götz; J Aston; M Drewe; U Gschwandtner; S Haller; M Pflüger; R-D Stieglitz; P K McGuire; A Riecher-Rössler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

8.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.

Authors:  Joseph H Callicott; Michael F Egan; Venkata S Mattay; Alessandro Bertolino; Ashley D Bone; Beth Verchinksi; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

9.  Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.

Authors:  Henning Witthaus; Christian Kaufmann; Georg Bohner; Seza Ozgürdal; Yehonala Gudlowski; Jürgen Gallinat; Stephan Ruhrmann; Martin Brüne; Andreas Heinz; Randolf Klingebiel; Georg Juckel
Journal:  Psychiatry Res       Date:  2009-07-17       Impact factor: 3.222

10.  Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Authors:  Dennis Velakoulis; Stephen J Wood; Michael T H Wong; Patrick D McGorry; Alison Yung; Lisa Phillips; De Smith; Warrick Brewer; Tina Proffitt; Patricia Desmond; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2006-02
View more
  32 in total

1.  Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

Authors:  André Schmidt; Renata Smieskova; Andor Simon; Paul Allen; Paolo Fusar-Poli; Philip K McGuire; Kerstin Bendfeldt; Jacqueline Aston; Undine E Lang; Marc Walter; Ernst-Wilhelm Radue; Anita Riecher-Rössler; Stefan J Borgwardt
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

2.  Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.

Authors:  Heidi W Thermenos; Richard J Juelich; Samantha R DiChiara; Raquelle I Mesholam-Gately; Kristen A Woodberry; Joanne Wojcik; Nikos Makris; Matcheri S Keshavan; Susan Whitfield-Gabrieli; Tsung-Ung W Woo; Tracey L Petryshen; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman
Journal:  Schizophr Res       Date:  2016-03-07       Impact factor: 4.939

Review 3.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

4.  Classification of first-episode psychosis: a multi-modal multi-feature approach integrating structural and diffusion imaging.

Authors:  Denis Peruzzo; Umberto Castellani; Cinzia Perlini; Marcella Bellani; Veronica Marinelli; Gianluca Rambaldelli; Antonio Lasalvia; Sarah Tosato; Katia De Santi; Vittorio Murino; Mirella Ruggeri; Paolo Brambilla
Journal:  J Neural Transm (Vienna)       Date:  2014-10-26       Impact factor: 3.575

5.  Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study.

Authors:  Dylan G Gee; Katherine H Karlsgodt; Theo G M van Erp; Carrie E Bearden; Matthew D Lieberman; Aysenil Belger; Diana O Perkins; Doreen M Olvet; Barbara A Cornblatt; Todd Constable; Scott W Woods; Jean Addington; Kristin S Cadenhead; Thomas H McGlashan; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-11-06       Impact factor: 4.939

6.  Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.

Authors:  Paul Klauser; Juan Zhou; Joseph K W Lim; Joann S Poh; Hui Zheng; Han Ying Tng; Ranga Krishnan; Jimmy Lee; Richard S E Keefe; R Alison Adcock; Stephen J Wood; Alex Fornito; Michael W L Chee
Journal:  Schizophr Bull       Date:  2015-03-04       Impact factor: 9.306

7.  Does neuroanatomy account for superior temporal dysfunction in early psychosis? A multimodal MRI investigation.

Authors:  William Pettersson-Yeo; Stefania Benetti; Silvia Frisciata; Marco Catani; Steve C R Williams; Paul Allen; Philip McGuire; Andrea Mechelli
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

Review 8.  Translational application of neuroimaging in major depressive disorder: a review of psychoradiological studies.

Authors:  Ziqi Chen; Xiaoqi Huang; Qiyong Gong; Bharat B Biswal
Journal:  Front Med       Date:  2021-01-29       Impact factor: 4.592

9.  Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study.

Authors:  Nenad Vasic; Nadine D Wolf; Georg Grön; Zrinka Sosic-Vasic; Bernhard J Connemann; Fabio Sambataro; Anna von Strombeck; Dirk Lang; Stefanie Otte; Manuela Dudek; Robert C Wolf
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

Review 10.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.